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Abstract
Background: Decision Aids (DAs) effectively translate medical evidence for patients
but are not routinely used in clinical practice. Little is known about how DAs are used
during patient-clinician encounters.
Objective: To characterize the content and communicative function of high-quality
DAs during diagnostic clinic visits for prostate cancer.
Participants: 252 men newly diagnosed with localized prostate cancer who had received a DA, 45 treating physicians at 4 US Veterans Administration urology clinics.
Methods: Qualitative analysis of transcribed audio recordings was used to inductively
develop categories capturing content and function of all direct references to DAs
(booklet talk). The presence or absence of any booklet talk per transcript was also
calculated.
Results: Booklet talk occurred in 55% of transcripts. Content focused on surgical procedures (36%); treatment choice (22%); and clarifying risk classification (17%). The
most common function of booklet talk was patient corroboration of physicians’ explanations (42%), followed by either physician or patient acknowledgement that the patient had the booklet. Codes reflected the absence of DA use for shared decision-making.
In regression analysis, predictors of booklet talk were fewer years of patient education
(P = .027) and more time in the encounter (P = .027). Patient race, DA type, time reading the DA, physician informing quality and physician age did not predict booklet talk.
Conclusions: Results show that good decision aids, systematically provided to patients, appeared to function not to open up deliberations about how to balance benefits and harms of competing treatments, but rather to allow patients to ask narrow
technical questions about recommended treatments.
KEYWORDS

decision aids, patient-centred communication, prostate cancer, qualitative research, shared
decision-making, veterans
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1 | INTRODUCTION

categories capturing content and function of direct references to DAs
(“booklet talk”). We also examined patient and clinician characteristics

Patient decision aids (DAs) describing treatment options and risk/ben-

associated with the presence of a reference to a DA during the en-

efit trade-offs among treatments have been successfully developed

counter. Understanding what content is discussed in direct reference

and tested over several decades, beginning, for early-stage prostate

to a DA, and how the DA functions in the encounter fills a knowledge

cancer, in 1988. . While DAs are effective information translation

gap about patient-clinician communication following standardized DA

tools, they are not routinely used in clinical practice.3 Systematic re-

provision. Understanding how DAs are discussed during encounters

views of DA tools show they increase patient knowledge, increase pa-

can help researchers and clinicians to design more effective DAs and

tient clarity about their own values, decrease decisional conflict and

implementation strategies.

1,2

increase patient interest in active roles in decision-making. However,
despite growing support for shared decision-making in practice guidelines and continued development of new DAs, little is known about

2 | METHODS

how patients and clinicians actually use DAs during clinical encounters.
DAs have been increasingly incorporated into communication and

Audio recordings and survey data were obtained from a multisite clini-

decision-making interventions.4 DAs are usually developed for those

cal trial that compared two prostate cancer DAs, to determine their

conditions that are preference sensitive, meaning conditions with

relative impact on treatment choice. Patients undergoing prostate biop-

competing treatment or screening options that offer similar survival,

sies were recruited from four US Veterans Administration (VA) Health

with different side-effect profiles. Initial treatment for clinically local-

Systems (Ann Arbor, Durham, Pittsburgh and San Francisco) between

ized prostate cancer provides the classic example of a preference sen-

September 2008 and May 2012. At recruitment, when the biopsy

sitive decision, as mortality is almost equivalent among surveillance

was performed, each patient was randomized to receive either a plain

(either active surveillance or watchful waiting), radiation therapy and

language DA (designed by the Michigan Cancer Consortium (MCC)19,

prostatectomy.5,6 Side effects of prostatectomy and radiation can in-

or a standard language DA (designed by the National Comprehensive

clude erectile dysfunction and bladder and bowel dysfunction, while

Cancer Network (NCCN) and American Cancer Society (ACS). The

surveillance requires follow-up testing and may cause anxiety about

MCC DA was developed to use plain language and to adhere to the

living with cancer.

standards of the International Patient Decision Aids Consortium

7-10

DAs have been implemented both in preparation for the clinical

(IPDAS).20 The current version of the MCC DA can be found at www.

encounter (with and without patient coaching) and within the clinical

prostatecancerdecision.org. The NCCN DA was chosen because of

encounter. The most recent update of the Cochrane Review of DAs

its high-quality information and the high credibility of the sponsoring

found that of 105 studies, implementation in preparation for the clin-

organizations. The current version of the NCCN DA can be found at

ical encounter occurred in 85% of included studies. Both implemen-

https://www.nccn.org/patients/guidelines/prostate.

tation strategies improved knowledge and more accurate patient risk

aids used the terminology “watchful waiting” because the term, “active

perceptions.

surveillance” was not a commonly used term when this study was con-

1

While previous studies have shown that DAs have potential to
positively impact both patient informing and patient-clinician interac-

Both

decision

ducted. Therefore, we use watchful waiting throughout. (More detailed
quality analysis of the DAs can be found in the Appendix S1).

tion, little is known about the role that DAs play during the exchanges

Block randomization was used to ensure that equal numbers of

between patients and clinicians. The impact of DAs on the clinical en-

African American and low-literacy patients received each decision

counter is assumed more often than examined. Of the 105 studies

aid. Physicians were aware that patients received a DA, but not given

included in the most recent Cochrane review, 10 studied the effect

any further instructions in DA use. In addition to transcripts of audio

on communication. Of those, the five studies that implemented the

recordings, survey data describing patient characteristics and self-

DA in preparation for the consultation all used self-report measures of

reported DA use were available for analysis from the parent trial.

1

To our knowledge, no previous study has used

Patients with clinically localized prostate cancer (Gleason score 6

data from direct observation of patient-clinician communication (ie,

or 7, PSA < 20 ng/mL) were asked to participate in audio recording of

data from transcripts or recordings of clinic visits) to identify how pa-

the first post-biopsy encounter, the one at which the patient first re-

tients and clinicians actually use and discuss DAs during encounters.

ceived his diagnosis and discussed initial treatment options. Surveys

Analysis of transcripts or recordings (rather than reports based on pa-

were administered at three time points: biopsy, immediately before the

decision-making.

11-15

and is

physician encounter and 7-10 days following the physician encounter.

generally considered the most accurate method for assessing the con-

Patients were called 2 days before the physician encounter and re-

16

tient or clinician recollection) is not subject to hindsight bias
tent of communication during clinic visits.

17,18

minded to read the DA, but were not informed of their diagnosis. They

In this study, we analysed visit transcripts to investigate the

learned their diagnosis from the physician, with the exception of one

content and communicative function of direct references to DAs in

site that followed a practice of giving the diagnosis over the telephone.

patients’ post-
biopsy urology clinic encounters during which ini-

Participants at that site were interviewed before the diagnosis phone

tial treatment decisions for clinically localized prostate cancer were

call. Physician participants were urology residents and attending phy-

made. We analysed transcripts for these visits to inductively develop

sicians. All provided demographic data at the time of recruitment. The

|
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study was approved by the VA Institutional Review Boards at each

random sample of 28 transcripts to evaluate whether booklet talk also

participating site; written informed consent was obtained from each

occurred in predictable portions of visits, for example. after diagnosis

patient and physician participant. The funding agencies had no role in

delivery, during treatment choice discussions, at the close of the en-

conduct or reporting of the parent study or the analysis presented in

counter. To do this, we calculated the percentage of total words in each

this manuscript.

transcript before each episode of booklet talk and analysed the distribution of results in the 28 randomly sampled transcripts. The wide

2.1 | Measures from the parent study

distribution of percentages of words before episodes of booklet talk
(range = 1-99) and no clear clustering pattern, suggested there was no

We obtained descriptive data from the parent study. Survey measures

part of the clinical routine that triggered booklet talk. We therefore did

completed by patients before the clinical encounter included patient

not pursue a separate structural analysis of the encounters.

literacy21 and numeracy22, preference for shared decision-making23,

In step two, we inductively developed the set of content and

prostate cancer treatment knowledge related to survival benefit and

function codes for each coded exchange by carefully analysing a ran-

side-effects associated with treatments,24-26 treatment preference,

dom pilot set of fourteen transcripts. No constraints were placed on

use of and satisfaction with DA and demographics (patients’ race, eth-

identification of content. Seven investigators independently applied

nicity, age, marital status and education).

the initial coding system to a second set of fourteen transcripts, re-

A measure of the quality of physician informing was obtained

solved disagreements and modified the coding system until the codes

through a transcript analysis. The Informed Decision Making (IDM)

could be applied reliably. Resulting content codes were: (i) treatment

score,

27

is a standardized observational measure of the quality of phy-

sician informing behaviour, scored by analysing transcripts of audio-
recorded patient encounters.28 Patients’ PSA level, Gleason Score and
treatment received were obtained from electronic medical records.

options, (ii) side-effects, (iii) treatment choice/decision, (iv) risk classification, (v) nature of cancer and (vi) booklet quality.
Function codes captured the conversational work being done by
booklet talk during the exchanges. Resulting function codes identified
that the speaker: (i) acknowledges the booklet, (ii) gives advice or in-

2.2 | Audio recordings and transcripts for this
analysis

formation, (iii) confirms or validates what was said, (iv) flags record-
keeping opportunity, (v) requests information, (vi) uses booklet to
question doctor and (vii) expresses concern or fear. Complete defini-

A research associate sets up an audio recorder in the examination

tions can be found in Tables 1 and 2. Each instance of booklet talk had

room at the start of each visit and then waited outside the exami-

at least one content and one function code. Codes were not mutually

nation room until the visit was complete. Recordings were later an-

exclusive, (eg, an exchange could have more than one content and/

onymized and transcribed verbatim. Of 256 transcripts, 252 were

or function code). We found no booklet talk exchanges that could be

available for inclusion. Two transcripts were excluded because of re-

considered shared decision-making. A final set of coding rules with ex-

corder malfunction; two encounters were only to obtain a referral to

amples was developed. Complete coding rules are available from the

radiation oncology. Time in the encounter was measured directly from

corresponding author.

the audio recordings. Time when the physician was out of the room

Six coders working in 3 pairs applied the final coding system to all

was subtracted from total time to yield the net time the physician was

252 transcripts. Two coders independently coded each transcript; dis-

in the room with the patient.

crepancies were resolved by consensus. Coders were blinded to plain
language vs standard language DA allocation. For rates of the presence

2.3 | Coding and qualitative analysis

or absence of booklet talk, the unit of analysis was the transcript. For
frequency of occurrence of content and function codes and for fre-

In this analysis, we coded and analysed direct references to the DA

quency of speaker exchanges, the unit of analysis was the total num-

and used a two-step coding process to identify the content catego-

ber of coded exchanges. To describe the distribution of content codes

ries and function categories to describe how the DA functioned in the

across all transcripts, we compiled all instances of each content code

exchange. In step one, two coders independently identified all direct

that appeared in the codebook. The denominator for this analysis (298

DA references. In addition, a word search of the text was performed

codes) exceeds the number of episodes across all transcripts because

using the words “booklet”, “pamphlet”, “book” and “decision aid” to

an episode could include more than one topic. Coding was completed

check for missing episodes. Booklet talk was classified into one of four

in Dedoose.32 Dedoose is, a Rich Internet Application (RIA) that allows

transactional categories: (i) patient initiates and doctor responds, (ii)

data analysis and handling from mixed methods research. Frequencies

patient initiates and doctor fails to respond, (iii) doctor initiates and

and descriptive statistics were calculated using Microsoft Excel.33

patient responds and (iv) doctor initiates and patient fails to respond.
Coding exchanges (ie, topic initiation and response) accounts for the
interactional nature of clinic visits and is a common approach when
coding patient-clinician communication.29,30

2.4 | Regression analysis
To identify predictors of booklet talk during the consultation, we con-

Because we previously noted that communication tasks during

ducted two mixed effects logistic regression models, using patient, phy-

these visits occurred in a predictable sequence,31 we analysed a

sician and encounter level variables from the parent study to predict the

282
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Content code

Content code definition

Frequency (%)

Treatment options

Booklet is referenced when discussing different
treatment options.

36

Treatment choice/
decision

Booklet is referenced when discussing making the
actual treatment decision

22

Risk classification

Booklet is referenced when discussing PSA, grade
and stage.

18

Side-effects

Booklet is referenced with respect to side-effects
of treatment options

8

Nature of cancer

Booklet is referenced with respect to the generally
slow growth of early-stage prostate CAs

8

Booklet quality

Any positive or negative statements regarding the
quality or utility of the booklet

8

Function code

Function code definition

Frequency (%)

Learn more or confirm/
validate

Doctor or patient utilizes the booklet to learn
more or validate something read in the booklet

41

Acknowledges booklet

Doctor or patient acknowledges the patient has
the booklet

28

Request for information
or question

Patient utilizes the booklet to ask a question

12

Advice or information
giving

Doctor utilizes the booklet to give advice or
provide the patient with more information

6

Record-keeping

Doctor or patient suggests writing notes in the
booklet

5

Uses booklet to question
doctor

Patient uses the booklet to challenge the
physician

4

Expression of concern

Doctor or patient expresses concern specifically
from something seen in the booklet

4

TABLE 1

Booklet talk content codes

TABLE 2

Booklet talk function codes

presence of booklet talk in the transcript. Among the variables available

completeness, we only evaluated cases that had complete data for

in the parent study, we prioritized those with a theoretical relationship

each variable in the models, making the final n in the mixed effects

to the likelihood of mentioning the DA in the encounter. Patient educa-

model 236/252 transcripts.

tion and race have been previously associated with how much patients
participate in encounters with physicians.34-37 Time spent reading the
DA before the encounter was included as a measure of interest in the

3 | RESULTS

content. Age was not included because of the narrow range of patient
ages. Time in the encounter, measured in minutes from the recordings,

Demographic characteristics for the 252 patients are shown in Table 3.

was included because trials of DAs have been shown across studies

The mean age of the patient sample was 63.3 years (SD = 5.9); 33%

to sometimes shorten and sometimes lengthen encounter times.38,39

were non-white; 40% had high school education or less. The mean age

DA type (plain vs standard language) was also included as a variable, as

of 45 treating physicians was 33 (SD = 7.2); 20% were women, 34%

randomization in the original study was based on DA type.

were non-white. On average, each physician was recorded in 6 clinical

The binary booklet talk variable (yes/no) was used as the main

encounters (SD = 4.3) and was 10 years post-graduation.

outcome in the logistic regression models. Specifically, to account for

References to a DA, (“booklet talk”), occurred in 138/252 tran-

patient, visit and physician variables in the models, two mixed effect

scripts (55%). In the 138 transcripts containing booklet talk, there

logistic regression models were conducted in Stata data analysis and

were 214 separate booklet talk episodes, with a maximum of 5 in a

statistical software version 14.040 (using the melogit command). The

single transcript, a mean of 1.55 (SD .81) and a mode of one. Of the

first model only included patient and visit level variables (ie, education,

214 booklet talk episodes, 120 (56%) were patient initiated. The ob-

race, DA type, time spent reading the DA and time in the encounter),

served rate of booklet talk per transcript was consistent with the rates

with physician ID number treated as a random intercept to account

reported in the surveys. In the post-encounter surveys, 55% of pa-

for potential variation by physician. The second model added physi-

tients reported bringing the DA to the encounter, while 90% reported

cian level variables, including physician age and the IDM score. For

reading the DA before the encounter (data available on request).

|
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TABLE 3

TABLE 4

Participant characteristics
Sample (n = 252)

Age

M = 63, SD = 6.01

Race (%)
Caucasian
African American
Other

185 (73)
67 (27)
0 (0)

Education (%)
<High school
High school grade/trade
Some college/Assoc.
BA+

5 (2)
79 (31)
116 (46)
52 (21)

Divorced/separated
Widowed
Single

Examples of booklet talk content codes

Treatment options
Example 1
PAT-Yeah, so removing the prostate effects what other body
functions or anything?
DOC-That’s basically it, urinary and erectile functions
PAT-Ok
DOC-No other real body functions
PAT-Body doesn’t need that
DOC-It needs it if you want kids, it needs it if you um. Yeah your
body doesn’t really need it
PAT-After reading that book, the radiation seems the better…… but
that’s not what you’re saying, it’s not really.
DOC-There’s benefits and risks to both

Marital status (%)
Married/partner

283

131 (52)
94 (37)
7 (3)
20 (8)

3.1 | Content and function

Example 2
PAT-In the book there was two types of radiation
DOC-Right there’s the seeds that they can put into your prostate or
radiation from the outside, where they focus all the energy
PAT-Some beam or something
DOC-Yeah external beam radiation
Treatment choice/decision

DAs were referenced most frequently during discussion of treatment

Example 1

options (36%). The most common specific content code was details of

PAT-I’ll just come back in like two to four weeks.

surgery. Direct references to making a treatment decision constituted

the encounter. As in the content codes, we compiled all instances of

DOC-Okay, alright. Um, I think that’s a very, very reasonable, um
again, this is a low risk prostate cancer. You’ve got good treatment
options available, and um, you’ll have the reading material that you
got from to kind of help you navigate these decisions. Um, if you
have any other questions or concerns, don’t hesitate to call back
over here to the clinic, you can talk to whichever one of the doctors
is down here.

each function code that appeared in the codebook. The denomina-

PAT- Okay.

tor for this analysis (316 codes), like content, exceeds the number of

DOC-Okay, and um, you know, we’re happy to kind of help you make
whatever decision it is that you want to make, whether that’s
surgery or radiation.

22% of all content codes; clarification of technical information about
risk classification, 18%. Frequencies for all content codes are shown in
Table 1, and examples of each content code appear in Table 4.
Function codes describe how the DA references were used in

episodes. All exchanges were coded for both content and function.
The functions were dominated by “learn more or validate” (41%) and
“acknowledging the booklet” (28%). “Learn more” was usually a pa-

Example 2

a DA or a comment that s/he saw the patient carrying a copy of the

DOC-Okay um, and even with aggressive disease….. the chance it can
affect your lifespan at five years is low. It interests me that some
patients say, “Listen I really want this tumor out.” And we get the
tumor out, it’s cancer, even despite the fact that I tell them that not
all cancer is the same.

DA. The third most frequent category was consistent with the design

PAT- Sure

of DAs, “using the booklet to ask a question” (12%). Examples of each

DOC- Okay

category of function codes appear in Table 5.

PAT-Well, like she had breast cancer and she immediately wanted it
out. I basically said the same thing the other day. If I find out I have
cancer I immediately want it out. But now, that I you know, read
some of that and after talking with you I got a little, “Yeah it’s, we’ll
do the wait and see approach for awhile.”

tient request to hear the physician’s explanation for or interpretation
of something the patient read in the DA. “Acknowledging the booklet”
was usually a physician question about whether the patient received

Occasionally, patients referred to the booklet to explain how worried they were about their prostate cancer or specific treatments. The
DA, in these instances, appeared to serve as either reassurance, or as
a vehicle for expressing concern to the physician. (See Table 5.) Patient
references to the DA to challenge the physician’s recommendation
were rare.

3.2 | Predictors of booklet talk
Results of the first mixed effects regression model revealed that only
education and time in the clinical encounter predicted reference to

DOC-The only caveat about the wait and see approach again is that,
you’re a little different than the typical wait and see approach patient.
Risk classification
PAT-I’m, I’m confused about the three plus three, I have to interrupt
you I’m sorry.
DOC-That’s no problem you can feel free to interrupt as, ask me
(Continues)
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TABLE 4

(Continued)

(Continued)

PAT-This book is talking about a PSA number and then they’re talking
about a Gleason s….

DOC- Yeah

DOC- Correct

DOC-The problem with those books is sometimes they are little bit
out of date.

PAT-What is the PSA number

PAT-That was pretty straight forward and simple and

DOC-His PSA is four point two
PAT-Four point two?

the booklet (ie, booklet talk). Specifically, higher education was associ-

DOC- Correct

ated with lower odds of the booklet’s being discussed in the clinical

PAT-The, the, the Gleason number you’re giving me you keep saying
three plus three?

encounter. Odds of booklet talk among patients with some college

DOC-Or six

P = .024) compared with those with a high school degree or less. Odds

PAT-So his Gleason number is six?

of booklet talk of those with a 4-year college degree and beyond had

DOC- Correct

an OR = 0.42 (95% CI = 0.18-0.96, P = .041) compared with those

PAT-In this book it’s saying a Gleason number of six is not the
slowest growing, it’s the medium

with a high school degree or less. Longer time spent in the clinical en-

or trade school education had an OR = 0.45 (95% CI = 0.22-0.90,

counter predicted higher odds of the DA being discussed (OR = 1.03,

DOC-No, it’s the slowest growing.

95% CI = 1.00-1.06, P = .034). We have previously shown that time

Side effects

in the encounter varied widely and was modestly associated (r = .24,

Example 1

P = .01) with the IDM score. In this analysis, time in the encounter, but

DOC-Okay, what would you like to hear more about? I mean I guess I
can talk most about the prostatectomy; do you have a thought?

spent reading the DA were not significant predictors of booklet talk.

not IDM score predicted booklet talk. Patient race, DA type and time
In the second model, we tested whether adding physician level

PAT-Well, you know they have these questions and I might ask them
in you know, how does the regular side effects in this booklet
compare to the regular side effects in your practice.

variables capturing physician experience and their quality of inform-

DOC: Oh, and I’m not sure what’s in the booklet, I should probably
read this a little more closely.

education and time in the encounter to drop out as significant pre-

Example 2

those with some college or trade school education (OR = 0.46, 95%

ing patients about treatment decision-making would cause patient
dictors. Patient’s level of education remained significant, but only for

PAT-And what’s that to do with, going the bathroom?

CI = 0.23-0.91, P = .027). In both models, men with only a high school

DOC-That is how you keep your urine in and not let it leak out

education referred to the booklet more often than more highly edu-

PAT-I thought I’d read some of that in there. I says, “I’d hate to have
to run into a problem like that.”

cated men. Time in the clinical encounter also remained significant.

DOC-Yeah. And that is a possibility, it is a slight possibility with
radiation as well but not as much. But those are your biggest
problems that we have, that we see with patients after surgery.

discussed (OR = 1.03, 95% CI = 1.00-1.07, P = .034). Patient race, DA

Nature of cancer
DOC-Yeah, and now we know so um we’ll have you come back in a
couple months
PAT- Ok
DOC- Alright
PAT-This type of cancer from what I read in the book is extremely
slow growing
DOC-Yes, but you seem healthy enough that you will probably live
another 20-30 y at least
PAT-That’s what I figured, you know I’m not that old yet

In longer clinical encounters, the booklet had higher odds of being
type, time spent reading the DA, the IDM score and physician age
were not significant predictors of booklet talk.

4 | DISCUSSION
While many DAs have been shown to be effective in translating medical evidence for patients, they are not routinely used in practice.1,3
Our results contribute to better understanding of this implementation
conundrum. We found that DAs appeared to function not to open up
deliberations about how to balance benefits and harms of competing
treatments, but to allow patients to ask narrow technical questions

Booklet quality

about recommended treatments. This was contrary to expectations,

DOC-Do you have access to the web?

as we chose high-quality DAs, shown previously to be engaging to

PAT- Yep

patients.19 We found no evidence that DAs functioned to facilitate

DOC-It does a pretty good job of um, um it does a pretty good job
about um, explaining treatment options and everything.

shared decision-making in the encounter.

PAT-Okay, better than this book that I got?

Direct references to the DA were more frequently initiated by patients

DOC- Yeah

Direct references to DAs occurred in over half of encounters.
than physicians. This may in part, be attributable to the fact that physi-

PAT- Really?

cians did not receive any training in DA use, while patients were asked
(Continues)

to use the DAs to prepare for the encounter. However, the analysis

|
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TABLE 5

TABLE 5

Examples of booklet talk function codes

Acknowledges booklet

(Continued)

PAT-Yeah…..gave me one book

PAT-Well uh, I kind of thought that if it was low grade or anything,
that uh, you know, we’d probably keep pretty close watch of it and
uh, monitor it closely and so on and if it reaches a stage where,
where, you know, where we determine that it needs pretty much,
you know, prompt attention and so on and so forth, why we’ll go
ahead and give it to it, you know, you know, just go ahead and give
it, do what’s necessary then in that case. I was leaning a little bit
towards treatment options of uh, now as far as percentage of cure
and so on, radiation as compared to surgery, what are the basic
percentages?

Example 2

Record-keeping

DOC-And have you done some reading about it?

PAT-Okay so that’s what they call, can we mark this down?

PAT-Yeah she gave me that book and that’s the only thing and I’m
not afraid of the procedure, it’s just the

PAT 2-Did you say its three?

DOC-The possibility of being incontinent afterwards

PAT-There’s places on that book they gave is very helpful so

PAT- Yeah

DOC-Sure, sure

Advice or information giving

PAT-I want to be able to fill that out, uh, as we’re going around.
We’re going to have some questions for you.

Example 1
DOC-It gives you time to digest, you seem like the type of guy that
you in good health will live a while longer so I do recommend some
type of treatment but what you choose is up to you. Both are equally
good
PAT-Is there literature
DOC-Yeah, they give you anything?

Example 1
DOC-You just have to remember like when you’re coming to see
urology. Okay, so, well I think if you all don’t have any other
questions, of course if you do have questions between now and then
PAT- Um-hmm
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DOC-Plus three, Gleason six,

Request for information or question
PAT-Now, again I’m going to ask the questions Doc, what grade is it?
DOC-Low grade

DOC-Just feel free to call us, or if you change your mind, you read
something in there and you say you know what I do want to talk to
the radiation doctors just give us a call, we can set that up.

PAT-Low grade, and it’s, the cells are they in the stage….. alright,
here’s what, and I don’t know I’m not a doctor, my son is but I’m not.
In this booklet that they got here, here we go. I’m a stage one or two
right?

Example 2

DOC-Stage one.

DOC-Okay? So let’s do this let’s return to clinic in 3 wk. Alright does
that sound like a good plan?

Uses booklet to question doctor

PAT- Yeah
DOC-And if you have any questions like I said, the handout is pretty
good it’s pretty detailed but it definitely will a
PAT- Yeah
DOC-You know help you maybe think through things and then
talking to the oncologist or to the radiation doctors would be great

DOC 1-That’s low grade, it goes from the Gleason.
PAT-If the high is ten, you’re over half.
DOC 2-Right, but the lowest grade that they call is six
DOC 1-Right
DOC 2-It’s a scale of six to ten, not, not zero to ten
PAT-Not according to this book
DOC 2-Yeah. Well the pathologists don’t call Gleason fives anymore,
they used to, but they don’t anymore.

Learn more or confirm/validate
Example 1
DOC-um, for people that have high risk cancer and sometimes people
have intermediate cancer we do get them the CAT scan and the
bone scan to make sure it’s nowhere else, but that’s typically for
higher risk, higher risk disease.
PAT-Yeah I was thinking, I read about that, that bone scan, CT scan
and whatever other scans they’ve got. You wouldn’t do that? I mean
that’s not, that’s not an option to do?
DOC-Oh, it’s, it’s, it’s typically you know, it’s, it’s not usually that it’s
not an option, it’s always an option. It’s just that for people with like
low and intermediate risk prostate cancer, it’s usually not necessary
because the odds that it’s spread are so low.

Expression of concern
Example 1
PAT-Whenever I start getting upset or nervous about this I can take
this out and start reading through it again. The way things are
explained in here kind of calms you down.
DOC-Well yeah, that’s good to know.
Example 2
DOC-Do you have access to the web?
DOC-Is that the material that they give you?
PAT 2-It’s the book, yeah. We both read it so

Example 2

DOC-I see

PAT-Right, and can you put some information in my booklet?

PAT 1-Gives you something

DOC-I sure can, I can do that. Why don’t I do this when we get
finished with this because yeah, I’ll put some information in here.
What are your thoughts about what you’ve read here?

DOC-It’s good, no, it’s an excellent resource. You know,

(Continues)

PAT 1-Well, it makes you sweat.
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of function codes revealed that patients largely used the DA to cor-

describing what issues from the DA were brought up, and how they

roborate what the physician said or to request more technical detail.

functioned in doctor-
patient communication about treatment de-

Specifically, 41% of booklet talk functioned to validate or prompt ad-

cisions for localized prostate cancer treatment. This augments prior

ditional discussion of a topic (“learn more”); the most common topic

research about DA effects based on self-report measures of patient-

discussed when referencing the DA was details of specific treatment

clinician communication. In these geographically distributed Veterans

options. Patients only used the DA as a platform for asking the physi-

Administration clinics, DAs were used as an adjunct to physician treat-

cian a question in 12% of transcripts (see Table 2). Patient questions

ment recommendations. A limitation of this study is that only explicit

were often about prognosis and treatment options. While it may be

mentions of DAs were coded. Other patient questions may have been

that patients with specific questions brought the DA along, it sug-

stimulated by DAs that were not explicitly linked to the DA as booklet

gests that encouragement to patients to bring a DA to the encounter

talk. However, as the field moves towards DA use to support decision-

may increase the likelihood that the DA content is discussed in the

making that reflects patient values, it will be critical to understand

encounter.

what actually happens during DA implementation in clinical encoun-

Patients did not use the DA to articulate their outcome prefer-

ters across settings.

ences and goals as encouraged in the DAs themselves. Nor did they
use the DA to bring up treatment outcomes or use the DA to say what
side-effects concerned them. Rather, booklet talk fit into a physician-
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driven medical routine focused on understanding biopsy results and
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gists’ recommendations, and not on patients’ personal views of the
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relative pros and cons of treatment alternatives. Urologists’ recom-
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mendations, in turn, were influenced heavily by medical factors (age

MCC) provided the plain language decision aid and the American

and Gleason score) but were unrelated to patient preferences. While
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booklet talk, suggesting that actual use of the DA in the encounter is a
generalizable phenomenon across different DAs.
Regression analysis showed that less well-educated patients were
more likely to mention the DA. This finding is not unexpected. In our
prior research, we found that patients with less education gained more
knowledge from a DA.42 It is one of the unique characteristics of DAs
that those who are less knowledgeable before reading a DA gain the
most knowledge. DAs are also designed to provide an authoritative
source to help patients ask questions.1 Time in the encounter, but not
the quality of physician informing (IDM score) predicted booklet talk.
This lends support to earlier findings that discussing patient questions
raised by a DA may take a small amount of extra time in the encounter.
The Cochrane Review of DAs shows that the association of DA use
with time in the encounter is highly variable, sometimes associated
with shorter and sometimes with longer encounters (range −4 minutes
to +23 minutes), with an average of 2.6 minutes longer1. It is important to note that in this study, which over-sampled African American
patients, race was not a predictor of booklet talk. This suggests that
minority and white patients were equally likely to use the DA in the
encounter.
While there are studies of patient-
clinician communication
focused on measuring the presence of shared decision-

making,43
we know of none that investigates how DAs function in real time
during the consultation. We extend previous research on DA use by
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